<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-18267" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Physiology, Bile Acids</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chen</surname>
            <given-names>Isaac</given-names>
          </name>
          <aff>California Northstate University College of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Cassaro</surname>
            <given-names>Sebastiano</given-names>
          </name>
          <aff>UN California Irvine / Kaweah Delta</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Isaac Chen declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sebastiano Cassaro declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-18267.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Bile acids are steroidal acids found in bile. Primary bile acids are steroids produced via the liver, specifically in peroxisomes.<xref ref-type="bibr" rid="article-18267.r1">[1]</xref><xref ref-type="bibr" rid="article-18267.r2">[2]</xref><xref ref-type="bibr" rid="article-18267.r3">[3]</xref>&#x000a0;There, the acids conjugate/connect to hydrophilic amino acids, namely glycine/taurine (i.e., conjugated bile acids called glycocholic and taurocholic acids, respectively); alongside sodium/potassium, they are termed bile salts.<xref ref-type="bibr" rid="article-18267.r4">[4]</xref><xref ref-type="bibr" rid="article-18267.r5">[5]</xref>&#x000a0;Secondary bile acids, however, are made via colonic bacteria. Of the organic compounds found in bile, bile acids constitute&#x000a0;the large majority.<xref ref-type="bibr" rid="article-18267.r6">[6]</xref><xref ref-type="bibr" rid="article-18267.r7">[7]</xref>&#x000a0;Right after being synthesized, bile acids are secreted into bile and concentrated for storage in the gallbladder. Eating then stimulates cholecystokinin release, which causes gallbladder contraction--releasing its bile acids into the duodenum through the sphincter of Oddi.<xref ref-type="bibr" rid="article-18267.r8">[8]</xref><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmid" xlink:href="31196634">[9]</ext-link> The more bile acid that gets secreted, the faster that bile flows. The primary purpose of bile acids is to facilitate the digestion of fat via its surfactant properties, which emulsify fats into micelles.<xref ref-type="bibr" rid="article-18267.r9">[10]</xref>&#x000a0;Hormonally, bile acids are also ligands for the farnesoid X receptor (FXR) and GPBAR1 (TGR5).<xref ref-type="bibr" rid="article-18267.r10">[11]</xref>&#x000a0;In sum, the three main functions of bile acids are to (1) emulsify fat, (2) excrete cholesterol, and (3) have an antimicrobial effect.<xref ref-type="bibr" rid="article-18267.r1">[1]</xref></p>
      </sec>
      <sec id="article-18267.s2" sec-type="Function">
        <title>Function</title>
        <p>Bile acids get conjugated in the liver to increase their water solubility because bile salts have a decreased pK, which favors the basic anionic form in the acidic duodenum. As amphiphiles, conjugated bile salts have a hydrophobic and hydrophilic side that, hence, their function as surfactants. The hydrophobic portion faces lipids, the hydrophilic portion facing the water, which allows them to act as bridges at the lipid/water interface, where they can make&#x000a0;micelles when sufficiently concentrated.<xref ref-type="bibr" rid="article-18267.r2">[2]</xref>&#x000a0;Micelles, with their bile acids, can support the function of lipases in digesting lipids and also bring them close to the intestine's brush border, augmenting their absorption.&#x000a0;Lipids are normally water-insoluble, and the stomach and intestines are full of water. If not for the action of bile, dietary lipids and water would not separate, and water-soluble lipases&#x000a0;would inefficiently exert their effects at the small interface between water and lipids. The emulsification of lipids by bile salts thus suspends lipid particles in water to dissolve them, accordingly granting significantly more surface area for lipase action.<xref ref-type="bibr" rid="article-18267.r9">[10]</xref><xref ref-type="bibr" rid="article-18267.r10">[11]</xref></p>
        <p>Other functions of bile acids include removing the body's cholesterol, powering bile flow to remove various metabolites (like bilirubin), and&#x000a0;facilitating the removal&#x000a0;of bacterial flora of the small bowel and biliary tree (e.g., by disrupting their cellular membranes).<xref ref-type="bibr" rid="article-18267.r6">[6]</xref>&#x000a0;Bile acids also hormonally act on&#x000a0;the FXR and TGR5 receptors. Control over bile acid concentrations is important because of their potential cytotoxicity, so FXR elicits functions primarily in the liver/intestines that include feedback regulation of bile acid&#x000a0;concentration, in addition to regulating triglyceride levels and other biochemical functions.<xref ref-type="bibr" rid="article-18267.r11">[12]</xref><xref ref-type="bibr" rid="article-18267.r12">[13]</xref><xref ref-type="bibr" rid="article-18267.r13">[14]</xref><xref ref-type="bibr" rid="article-18267.r14">[15]</xref>&#x000a0;Secondary bile acids, e.g., deoxycholic acid, may have implications in&#x000a0;more strongly downregulating bile acid synthesis than primary bile acids when it comes to negative feedback.<xref ref-type="bibr" rid="article-18267.r15">[16]</xref> The TGR5 receptor is involved in the regulation of energy homeostasis by bile acids.<xref ref-type="bibr" rid="article-18267.r16">[17]</xref><xref ref-type="bibr" rid="article-18267.r17">[18]</xref>&#x000a0;In addition to its effects on the above-mentioned hormone receptors, bile acids target other proteins like N-acyl phosphatidylethanolamine-specific phospholipase D, involved in pathways related to stress/pain responses, appetite, and lifespan via crosstalk between lipid amide signals with bile acids. Other miscellaneous functions under&#x000a0;the purview of bile acids potentially include the regulation of particular enzymes/ion channels and the synthesis of various substances.<xref ref-type="bibr" rid="article-18267.r18">[19]</xref><xref ref-type="bibr" rid="article-18267.r19">[20]</xref><xref ref-type="bibr" rid="article-18267.r20">[21]</xref><xref ref-type="bibr" rid="article-18267.r16">[17]</xref></p>
      </sec>
      <sec id="article-18267.s3" sec-type="Mechanism">
        <title>Mechanism</title>
        <p>Altogether, bile salts comprise a broad variety of different molecules, each being a steroid with the following basic components: (1)&#x000a0;4 rings, (2) a 5-/8-carbon side chain that ends with a carboxylic acid, and (3) a number of hydroxyl groups (whose position/number changes among the various salts). The rings are ascribed the letters A, B, C, and D based on their distance from the side chain with the -COOH group, the D ring being the most distant (as well as being 1 C smaller than the other rings). Beta hydroxyl groups face up/out, alpha groups down, and every bile acid has a 3-hydroxyl group that came from their cholesterol precursor.<xref ref-type="bibr" rid="article-18267.r1">[1]</xref></p>
        <p>Primary bile acids are made by hepatocytes either by the classic or acidic pathway. The former, which constitutes 95% of bile acid synthesis, is via cytochrome P450-mediated oxidation of cholesterol that requires NADPH and oxygen and occurs in a series of steps, the most important of which is the rate-limiting hydroxylation of the 7th steroid nucleus of cholesterol by cholesterol 7alpha-hydroxylase (CYP7A1) to create 7alpha-hydroxycholesterol. That then gets metabolized into 7alpha-hydroxy-4 cholesten-3-one in the second step. In sum, primary bile acid synthesis requires 14 enzymatic steps. The most common bile acids are cholic and chenodeoxycholic acid (CDCA). Cholic acid (3alpha, 7alpha, 12alpha-trihydroxy-5beta-cholan-24-oic acid) is the commonest bile acid, and CDCA is the&#x000a0;prototypical and most basic&#x000a0;of bile acids produced and is also known as 3alpha,7alpha-dihydroxy-5beta-cholan-24-oic acid.<xref ref-type="bibr" rid="article-18267.r4">[4]</xref>&#x000a0;</p>
        <p>The alternative/acidic pathway acts via mitochondrial sterol 27-hydroxylase (CYP27A1), found in the liver, macrophages, and other tissues. Before secretion of bile acids, hepatocytes conjugate them with the amino acids taurine or glycine, thereby creating eight different conjugated bile acids/salts (including cholic and chenocholic acids). CYP27A1 significantly adds to bile acid synthesis by facilitating the oxidation of sterol side chains, followed by a peroxisomal cleavage of a 3-C unit to generate a C24 bile acid. Miscellaneous pathways, in addition to these two, include those started by the liver's 25-hydroxylase and the brain's 24-hydroxylase.&#x000a0;</p>
        <p>The purpose of conjugation is so that the bile acids can become water-soluble and thereby emulsify fats.<xref ref-type="bibr" rid="article-18267.r2">[2]</xref> Secondary bile acids are formed from bacterial deconjugation/dehydroxylation and removal of those amino acid groups, creating four more different types of bile acids (including deoxycholic and lithocholic acids). These acids are absorbed through the bloodstream and brought back to the liver via the enterohepatic circulation to then be resecreted. Most triglyceride absorption occurs at the jejunum, but the conjugated bile acids do not get absorbed along with them. Instead, the bile salts remain in the small intestine, where most are later absorbed and recycled by active transport at the terminal ileum (the remaining undergo fecal elimination). The end of the small intestine acting the site of bile salt absorption allows for a high concentration of bile salts to exist throughout the entire organ, maximizing lipid digestion and absorption.<xref ref-type="bibr" rid="article-18267.r5">[5]</xref></p>
      </sec>
      <sec id="article-18267.s4" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Bile acid synthesis defects comprise about 1 to 2% of the cholestatic diseases found in children.<xref ref-type="bibr" rid="article-18267.r21">[22]</xref> With an autosomal recessive inheritance pattern, these defects have a spectrum of disease severity based on what they affect. Most commonly, these manifest as progressive cholestasis of infancy, in addition to other disorders like an advanced liver disease at birth or neonatal hepatitis; patients may also develop a liver disease later in childhood. Typically, an earlier onset of liver disease occurs with those enzymatic defects that result in a buildup of oxo-bile acids, which tend to be cholestatic.<xref ref-type="bibr" rid="article-18267.r22">[23]</xref>&#x000a0;Adult liver disease may also have a connection to inherited defects in bile synthesis, as well.<xref ref-type="bibr" rid="article-18267.r23">[24]</xref></p>
      </sec>
      <sec id="article-18267.s5" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Impairing enterohepatic circulation of bile acids decreases cholesterol because the liver is driven to use more cholesterol to make more. This state is the basis behind treating hyperlipidemia with bile acid resins like cholestyramine, colestipol, and colesevelam, which bind bile acids in the gut, preventing their reabsorption in the intestines. The bound bile acids are then fecally removed. However, because bile acid sequestrants also interfere with the absorption of fat, the absorption of drugs and fat-soluble vitamins are impaired.<xref ref-type="bibr" rid="article-18267.r24">[25]</xref>&#x000a0;</p>
        <p>Structural/functional abnormalities of the biliary tract can produce an increase in bilirubin, causing jaundice, as well as an increase in serum bile acids. This observed cholestasis (disrupted bile flow to intestines) may also present with primary sclerosing cholangitis, intrahepatic cholestasis of pregnancy, and primary biliary cholangitis, where the buildup of bile acids can lead to pruritus because of the bile salts in skin.<xref ref-type="bibr" rid="article-18267.r25">[26]</xref>&#x000a0;Treating these disorders has involved ursodeoxycholic acid (ursodiol), a non-toxic bile acid that increases bile secretion and decreases cholesterol secretion/absorption. Obeticholic acid is a semisynthetic bile acid that can also treat primary biliary cirrhosis by stimulating FXR.<xref ref-type="bibr" rid="article-18267.r26">[27]</xref><xref ref-type="bibr" rid="article-18267.r27">[28]</xref></p>
        <p>Bile that has diluted concentrations of bile acids or phospholipids, in addition to increased cholesterol, leads to a decrease in the solubilization of cholesterol. This situation increases the risk for microcrystal formation from this supersaturated bile--eventually leading to the formation of cholesterol stones. Fibrates like gemfibrozil, bezafibrate, and fenofibrate also increase the risk of cholesterol gallstones by inhibiting cholesterol-7alpha-hydroxylase, resulting in decreased bile acid production.<xref ref-type="bibr" rid="article-18267.r28">[29]</xref> Dissolution or prevention of these gallstones occurs with bile acid administration, in the form of chenodeoxycholic and/or ursodeoxycholic acid.<xref ref-type="bibr" rid="article-18267.r29">[30]</xref><xref ref-type="bibr" rid="article-18267.r30">[31]</xref>&#x000a0;</p>
        <p>Too much bile acid in the colon may precipitate chronic diarrhea, which may occur in conditions that impair the ileal absorption of bile salts, as seen with surgical removal for Crohn disease (which normally causes fat malabsorption by affecting the terminal ileum). Such malabsorption of bile acids is treatable with bile acid resins.<xref ref-type="bibr" rid="article-18267.r31">[32]</xref></p>
        <p>There may also exist a link between bile acids and colorectal cancer.<xref ref-type="bibr" rid="article-18267.r32">[33]</xref>&#x000a0;Specifically, low fecal concentrations of bile acids have correlations with lower rates of colorectal cancer.<xref ref-type="bibr" rid="article-18267.r33">[34]</xref><xref ref-type="bibr" rid="article-18267.r34">[35]</xref><xref ref-type="bibr" rid="article-18267.r35">[36]</xref>&#x000a0;One potential explanation is that high concentrations of deoxycholic acid, a type of bile acid, can increase the generation of reactive oxygen species that can go on to damage DNA.<xref ref-type="bibr" rid="article-18267.r36">[37]</xref><xref ref-type="bibr" rid="article-18267.r33">[34]</xref></p>
        <p>Bile acids have also been used to get rid of undesired fat, i.e., mesotherapy, with deoxycholic acid being one such drug.<xref ref-type="bibr" rid="article-18267.r37">[38]</xref><xref ref-type="bibr" rid="article-18267.r38">[39]</xref></p>
      </sec>
      <sec id="article-18267.s6">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18267&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18267">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/18267/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=18267">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-18267.s7">
        <fig id="article-18267.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Recycling of bile Image courtesy: https://commons.wikimedia.org/wiki/File:Bile_recycling.png</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Bile_recycling" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-18267.s8">
        <title>References</title>
        <ref id="article-18267.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hofmann</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Hagey</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Krasowski</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Bile salts of vertebrates: structural variation and possible evolutionary significance.</article-title>
            <source>J Lipid Res</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>226</fpage>
            <page-range>226-46</page-range>
            <pub-id pub-id-type="pmid">19638645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>HOFMANN</surname>
                <given-names>AF</given-names>
              </name>
            </person-group>
            <article-title>THE FUNCTION OF BILE SALTS IN FAT ABSORPTION. THE SOLVENT PROPERTIES OF DILUTE MICELLAR SOLUTIONS OF CONJUGATED BILE SALTS.</article-title>
            <source>Biochem J</source>
            <year>1963</year>
            <month>Oct</month>
            <volume>89</volume>
            <issue>1</issue>
            <fpage>57</fpage>
            <page-range>57-68</page-range>
            <pub-id pub-id-type="pmid">14097367</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferdinandusse</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Houten</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Peroxisomes and bile acid biosynthesis.</article-title>
            <source>Biochim Biophys Acta</source>
            <year>2006</year>
            <month>Dec</month>
            <volume>1763</volume>
            <issue>12</issue>
            <fpage>1427</fpage>
            <page-range>1427-40</page-range>
            <pub-id pub-id-type="pmid">17034878</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carey</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Small</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Micelle formation by bile salts. Physical-chemical and thermodynamic considerations.</article-title>
            <source>Arch Intern Med</source>
            <year>1972</year>
            <month>Oct</month>
            <volume>130</volume>
            <issue>4</issue>
            <fpage>506</fpage>
            <page-range>506-27</page-range>
            <pub-id pub-id-type="pmid">4562149</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chiang</surname>
                <given-names>JY</given-names>
              </name>
            </person-group>
            <article-title>Bile acids: regulation of synthesis.</article-title>
            <source>J Lipid Res</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>50</volume>
            <issue>10</issue>
            <fpage>1955</fpage>
            <page-range>1955-66</page-range>
            <pub-id pub-id-type="pmid">19346330</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hofmann</surname>
                <given-names>AF</given-names>
              </name>
            </person-group>
            <article-title>The continuing importance of bile acids in liver and intestinal disease.</article-title>
            <source>Arch Intern Med</source>
            <year>1999</year>
            <month>Dec</month>
            <day>13-27</day>
            <volume>159</volume>
            <issue>22</issue>
            <fpage>2647</fpage>
            <page-range>2647-58</page-range>
            <pub-id pub-id-type="pmid">10597755</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Staels</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fonseca</surname>
                <given-names>VA</given-names>
              </name>
            </person-group>
            <article-title>Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration.</article-title>
            <source>Diabetes Care</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>32 Suppl 2</volume>
            <issue>Suppl 2</issue>
            <fpage>S237</fpage>
            <page-range>S237-45</page-range>
            <pub-id pub-id-type="pmid">19875558</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chiang</surname>
                <given-names>JY</given-names>
              </name>
            </person-group>
            <article-title>Bile acid signaling in metabolic disease and drug therapy.</article-title>
            <source>Pharmacol Rev</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>66</volume>
            <issue>4</issue>
            <fpage>948</fpage>
            <page-range>948-83</page-range>
            <pub-id pub-id-type="pmid">25073467</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>HOFMANN</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>BORGSTROEM</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>THE INTRALUMINAL PHASE OF FAT DIGESTION IN MAN: THE LIPID CONTENT OF THE MICELLAR AND OIL PHASES OF INTESTINAL CONTENT OBTAINED DURING FAT DIGESTION AND ABSORPTION.</article-title>
            <source>J Clin Invest</source>
            <year>1964</year>
            <month>Feb</month>
            <volume>43</volume>
            <issue>2</issue>
            <fpage>247</fpage>
            <page-range>247-57</page-range>
            <pub-id pub-id-type="pmid">14162533</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fiorucci</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mencarelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Palladino</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cipriani</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders.</article-title>
            <source>Trends Pharmacol Sci</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>30</volume>
            <issue>11</issue>
            <fpage>570</fpage>
            <page-range>570-80</page-range>
            <pub-id pub-id-type="pmid">19758712</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ahn</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Inagaki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ito</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Kliewer</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Gonzalez</surname>
                <given-names>FJ</given-names>
              </name>
            </person-group>
            <article-title>Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine.</article-title>
            <source>J Lipid Res</source>
            <year>2007</year>
            <month>Dec</month>
            <volume>48</volume>
            <issue>12</issue>
            <fpage>2664</fpage>
            <page-range>2664-72</page-range>
            <pub-id pub-id-type="pmid">17720959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Makishima</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Okamoto</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Repa</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Tu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Learned</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Luk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hull</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Lustig</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Mangelsdorf</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Shan</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Identification of a nuclear receptor for bile acids.</article-title>
            <source>Science</source>
            <year>1999</year>
            <month>May</month>
            <day>21</day>
            <volume>284</volume>
            <issue>5418</issue>
            <fpage>1362</fpage>
            <page-range>1362-5</page-range>
            <pub-id pub-id-type="pmid">10334992</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parks</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Blanchard</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Bledsoe</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Chandra</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Consler</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Kliewer</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Stimmel</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Willson</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Zavacki</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Lehmann</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Bile acids: natural ligands for an orphan nuclear receptor.</article-title>
            <source>Science</source>
            <year>1999</year>
            <month>May</month>
            <day>21</day>
            <volume>284</volume>
            <issue>5418</issue>
            <fpage>1365</fpage>
            <page-range>1365-8</page-range>
            <pub-id pub-id-type="pmid">10334993</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hollister</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sowers</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Forman</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Endogenous bile acids are ligands for the nuclear receptor FXR/BAR.</article-title>
            <source>Mol Cell</source>
            <year>1999</year>
            <month>May</month>
            <volume>3</volume>
            <issue>5</issue>
            <fpage>543</fpage>
            <page-range>543-53</page-range>
            <pub-id pub-id-type="pmid">10360171</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stange</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Scheibner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ditschuneit</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Role of primary and secondary bile acids as feedback inhibitors of bile acid synthesis in the rat in vivo.</article-title>
            <source>J Clin Invest</source>
            <year>1989</year>
            <month>Jul</month>
            <volume>84</volume>
            <issue>1</issue>
            <fpage>173</fpage>
            <page-range>173-80</page-range>
            <pub-id pub-id-type="pmid">2738150</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jiao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>XY</given-names>
              </name>
            </person-group>
            <article-title>Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis.</article-title>
            <source>Acta Pharmacol Sin</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>44</fpage>
            <page-range>44-50</page-range>
            <pub-id pub-id-type="pmid">25500875</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baxter</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Webb</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Metabolism: bile acids heat things up.</article-title>
            <source>Nature</source>
            <year>2006</year>
            <month>Jan</month>
            <day>26</day>
            <volume>439</volume>
            <issue>7075</issue>
            <fpage>402</fpage>
            <page-range>402-3</page-range>
            <pub-id pub-id-type="pmid">16437098</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nagahashi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Takabe</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hait</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Allegood</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Yamada</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Aoyagi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pandak</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Spiegel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hylemon</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression.</article-title>
            <source>Hepatology</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>61</volume>
            <issue>4</issue>
            <fpage>1216</fpage>
            <page-range>1216-26</page-range>
            <pub-id pub-id-type="pmid">25363242</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wiemuth</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sahin</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Falkenburger</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Lef&#x000e8;vre</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Wasmuth</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Gr&#x000fc;nder</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>BASIC--a bile acid-sensitive ion channel highly expressed in bile ducts.</article-title>
            <source>FASEB J</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>26</volume>
            <issue>10</issue>
            <fpage>4122</fpage>
            <page-range>4122-30</page-range>
            <pub-id pub-id-type="pmid">22735174</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Magotti</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Igarashi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Babagoli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marotta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Piomelli</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Garau</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Structure of human N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: regulation of fatty acid ethanolamide biosynthesis by bile acids.</article-title>
            <source>Structure</source>
            <year>2015</year>
            <month>Mar</month>
            <day>03</day>
            <volume>23</volume>
            <issue>3</issue>
            <fpage>598</fpage>
            <page-range>598-604</page-range>
            <pub-id pub-id-type="pmid">25684574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bove</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Heubi</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Balistreri</surname>
                <given-names>WF</given-names>
              </name>
              <name>
                <surname>Setchell</surname>
                <given-names>KD</given-names>
              </name>
            </person-group>
            <article-title>Bile acid synthetic defects and liver disease: a comprehensive review.</article-title>
            <source>Pediatr Dev Pathol</source>
            <year>2004</year>
            <season>Jul-Aug</season>
            <volume>7</volume>
            <issue>4</issue>
            <fpage>315</fpage>
            <page-range>315-34</page-range>
            <pub-id pub-id-type="pmid">15383928</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stieger</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>O'Neill</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sj&#x000f6;vall</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Meier</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Differential interaction of bile acids from patients with inborn errors of bile acid synthesis with hepatocellular bile acid transporters.</article-title>
            <source>Eur J Biochem</source>
            <year>1997</year>
            <month>Feb</month>
            <day>15</day>
            <volume>244</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-44</page-range>
            <pub-id pub-id-type="pmid">9063443</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fischler</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bodin</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Stjernman</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Olin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hansson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sj&#x000f6;vall</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bj&#x000f6;rkhem</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Cholestatic liver disease in adults may be due to an inherited defect in bile acid biosynthesis.</article-title>
            <source>J Intern Med</source>
            <year>2007</year>
            <month>Aug</month>
            <volume>262</volume>
            <issue>2</issue>
            <fpage>254</fpage>
            <page-range>254-62</page-range>
            <pub-id pub-id-type="pmid">17645593</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davidson</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>A systematic review of bile acid sequestrant therapy in children with familial hypercholesterolemia.</article-title>
            <source>J Clin Lipidol</source>
            <year>2011</year>
            <season>Mar-Apr</season>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>76</fpage>
            <page-range>76-81</page-range>
            <pub-id pub-id-type="pmid">21392720</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pusl</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Beuers</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Intrahepatic cholestasis of pregnancy.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2007</year>
            <month>May</month>
            <day>29</day>
            <volume>2</volume>
            <fpage>26</fpage>
            <pub-id pub-id-type="pmid">17535422</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poupon</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Balkau</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Eschw&#x000e8;ge</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Poupon</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group.</article-title>
            <source>N Engl J Med</source>
            <year>1991</year>
            <month>May</month>
            <day>30</day>
            <volume>324</volume>
            <issue>22</issue>
            <fpage>1548</fpage>
            <page-range>1548-54</page-range>
            <pub-id pub-id-type="pmid">1674105</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glantz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marschall</surname>
                <given-names>HU</given-names>
              </name>
              <name>
                <surname>Lammert</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mattsson</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.</article-title>
            <source>Hepatology</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>42</volume>
            <issue>6</issue>
            <fpage>1399</fpage>
            <page-range>1399-405</page-range>
            <pub-id pub-id-type="pmid">16317669</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Post</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Duez</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gervois</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Staels</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kuipers</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Princen</surname>
                <given-names>HM</given-names>
              </name>
            </person-group>
            <article-title>Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression.</article-title>
            <source>Arterioscler Thromb Vasc Biol</source>
            <year>2001</year>
            <month>Nov</month>
            <volume>21</volume>
            <issue>11</issue>
            <fpage>1840</fpage>
            <page-range>1840-5</page-range>
            <pub-id pub-id-type="pmid">11701475</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Danzinger</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Hofmann</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Schoenfield</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Thistle</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Dissolution of cholesterol gallstones by chenodeoxycholic acid.</article-title>
            <source>N Engl J Med</source>
            <year>1972</year>
            <month>Jan</month>
            <day>06</day>
            <volume>286</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-8</page-range>
            <pub-id pub-id-type="pmid">5006919</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thistle</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Hofmann</surname>
                <given-names>AF</given-names>
              </name>
            </person-group>
            <article-title>Efficacy and specificity of chenodeoxycholic acid therapy for dissolving gallstones.</article-title>
            <source>N Engl J Med</source>
            <year>1973</year>
            <month>Sep</month>
            <day>27</day>
            <volume>289</volume>
            <issue>13</issue>
            <fpage>655</fpage>
            <page-range>655-9</page-range>
            <pub-id pub-id-type="pmid">4580472</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pattni</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Walters</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Recent advances in the understanding of bile acid malabsorption.</article-title>
            <source>Br Med Bull</source>
            <year>2009</year>
            <volume>92</volume>
            <fpage>79</fpage>
            <page-range>79-93</page-range>
            <pub-id pub-id-type="pmid">19900947</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Degirolamo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Modica</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Palasciano</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Moschetta</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Bile acids and colon cancer: Solving the puzzle with nuclear receptors.</article-title>
            <source>Trends Mol Med</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>17</volume>
            <issue>10</issue>
            <fpage>564</fpage>
            <page-range>564-72</page-range>
            <pub-id pub-id-type="pmid">21724466</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reddy</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Hanson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mangat</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mathews</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sbaschnig</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Simi</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Effect of high-fat, high-beef diet and of mode of cooking of beef in the diet on fecal bacterial enzymes and fecal bile acids and neutral sterols.</article-title>
            <source>J Nutr</source>
            <year>1980</year>
            <month>Sep</month>
            <volume>110</volume>
            <issue>9</issue>
            <fpage>1880</fpage>
            <page-range>1880-7</page-range>
            <pub-id pub-id-type="pmid">7411244</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hill</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Bile flow and colon cancer.</article-title>
            <source>Mutat Res</source>
            <year>1990</year>
            <month>May</month>
            <volume>238</volume>
            <issue>3</issue>
            <fpage>313</fpage>
            <page-range>313-20</page-range>
            <pub-id pub-id-type="pmid">2188127</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheah</surname>
                <given-names>PY</given-names>
              </name>
            </person-group>
            <article-title>Hypotheses for the etiology of colorectal cancer--an overview.</article-title>
            <source>Nutr Cancer</source>
            <year>1990</year>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>5</fpage>
            <page-range>5-13</page-range>
            <pub-id pub-id-type="pmid">2195469</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bernstein</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bernstein</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Payne</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Dvorak</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Bile acids as endogenous etiologic agents in gastrointestinal cancer.</article-title>
            <source>World J Gastroenterol</source>
            <year>2009</year>
            <month>Jul</month>
            <day>21</day>
            <volume>15</volume>
            <issue>27</issue>
            <fpage>3329</fpage>
            <page-range>3329-40</page-range>
            <pub-id pub-id-type="pmid">19610133</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ascher</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hoffmann</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lippert</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wollina</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Havlickova</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>28</volume>
            <issue>12</issue>
            <fpage>1707</fpage>
            <page-range>1707-15</page-range>
            <pub-id pub-id-type="pmid">24605812</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18267.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wollina</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Goldman</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>ATX-101 for reduction of submental fat.</article-title>
            <source>Expert Opin Pharmacother</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>16</volume>
            <issue>5</issue>
            <fpage>755</fpage>
            <page-range>755-62</page-range>
            <pub-id pub-id-type="pmid">25724831</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
